PDF
ePub
Citation
Print
Abstract
Excessive stress gives rise to disturbances in various systems in humans and activates defense mechanisms to maintain homeostasis in the body. Sleep is an essential biological process of which the underlying regulating mechanism involves numerous anatomical structures and biochemical substances that can be compromised by stress and the immune system. Immune sub-stances such as interleukin-1β and tumor necrosis factor are related to the homeostatic process of sleep. Interleukin-1β interacts by being involved in an immune regulating feedback chain that activates the hypothalamo-pituitary-adrenal axis which, in turn, is related to the circadian process. Moreover, stress-induced insomnia activates the hypothalamo-pituitary-adrenal axis further to bring about a vicious cycle of stress and insomnia. The pathophysiological theory responsible for chronic insomnia is that of stressdiathesis, which is a series of processes consisting of predisposition, precipitating, and perpetuating factors. In clinical practice, as the process in which stressinduced insomnia passes into a chronic course is directly related to treatment, the understanding of perpetuating factors is indispensable. Sleep disturbance is a very common complaint among pa-tients with posttraumatic stress disorder. Increased noradrenergic activity and REM sleep dysregul-ation seem to have a role in mediating sleep disturbances of this disorder. Sleep disturbance must always be taken into account as an important clinical variable whenever evaluating or managing stress.
References
1. Gooley JJ, Lu J, Fischer D, Saper CB. A broad role for melanopsin in nonvisual photoreception. J Neurosci. 1991. 23:7093–7106.
2. Deurveilher S, Semba K. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience. 2005. 130:165–183.
3. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci. 2001. 4:732–738.
4. Saper CB, Lu J, Chou TC, Gooley J. The hypothalamic integrator for circadian rhythms. Trends Neurosci. 2005. 28:152–157.
5. Lewy AJ, Cutler NL, Sack RL. The endogenous melatonin profile as a marker for circadian phase position. J Biol Rhythms. 1999. 14:227–236.
6. Buijs RM, Wortel J, Van Heerikhuize JJ, Feenstra MG, Ter Horst GJ, Romijn HJ, Kalsbeek A. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci. 1999. 11:1535–1544.
7. Berridge CW, Foote SL. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci. 1991. 11:3135–3145.
8. Franken P, Dijk DJ, Tobler I, Borberly AA. Sleep deprivartion in the rat: Effects of EEG power spectra, vigilence states, and cortical temperature. Am J Physiol. 1991. 261:198–208.
9. Ko EM, Estabrooke IV, McCarthy M, Scammell TE. Wake-related activity of tuberomammillary neurons in rats. Brain Res. 2003. 992:220–226.
10. Gallopin T, Fort P, Eggermann E, Cauli B, Luppi PH, Rossier J, Audinat E, Mühlethaler M, Serafin M. Identification of sleep-promoting neurons in vitro. Nature. 2000. 404:992–995.
11. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic neurons during sleep. Science. 1996. 271:216–219.
12. Gallopin T, Luppi PH, Cauli B, Urade Y, Rossier J, Hayaishi O, Lambolez B, Fort P. The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A2A receptors in the ventrolateral preoptic nucleus. Neuroscience. 2005. 134:1377–1390.
13. Basheer R, Strecker RE, Thakkar MM, McCarley RW. Adenosine and sleep-wake regulation. Prog Neurobiol. 2004. 73:379–396.
14. Obal F Jr, Krueger JM. Biological Regulation of Non-Rapid-Eye-Movement Sleep. Frontiers in Bioscience. 2003. 8:520–550.
15. Majde JA. Viral double-stranded RNA, cytokines and the flu. J Interferon Cytok Res. 2000. 20:259–272.
16. Yoshida H, Peterfi Z, Garcia-Garcia F, Kirkpatrick R, Yasuda T, Krueger JM. Asymmetries in slow wave sleep EEG induced by local application of TNFα. Brain Res. 2004. 1009:129–136.
17. McCann SM, Kimura M, Karanth S, Yu WH, Rettori V. Role of nitric oxide in the neuroendocrine response to cytokines. Front Horm Res. 2002. 29:117–129.
18. Luk WP, Zhang Y, White TD, Lue FA, Wu C, Jiang CG, Zhang L, Moldofsky H. Adenosine: a mediator of interleukin-1 beta-induced hippocampal synaptic inhibition. J Neurosci. 1999. 19:4238–4244.
19. Brown MR, McCubbin J, Kaufman P, Niemeroff C. Neuropeptide-mediated regulation of the neuroendocrine and autonomicn responses to stress. Stress, neuropeptides, and systemic disease. 1991.
20. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. J Am Med Assoc. 1992. 267:1244–1252.
21. McEwen BS, Sapolsky RM. Stress and cognitive function. Curr Opin Neurobiol. 1995. 5:205–216.
22. Born J, Hansen K, Marshall L, Molle M, Fehm HL. Timing the end of nocturnal sleep. Nature. 1999. 397:29–30.
23. Born J, Fehm H. Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes. 1998. 106:153–163.
24. Meerlo P, Pragt B, Daan S. Social stress induces high intensity sleep in rats. Neurosci Lett. 1997. 255:41–44.
25. Marinesco S, Bonnet C, Cespuglio R. Influence of stress duration on the sleep rebound induced by immobilization in the rat: a possible role for corticosterone. Neuroscience. 1999. 92:921–933.
26. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA. 2003. 100:1920–1925.
27. Benschop RJ, Godaert GL, Geenen R, Brosschot JF, De Smet MB, Olff M, Heijnen CJ, Ballieux RE. Relationships between cardiovascular and immunological changes in an experimental stress model. PsycholMed. 1995. 25:323–327.
28. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and health consequences: data andshared mechanisms. Psychosom Med. 1995. 57:269–274.
29. Irwin M, Smith TL, Gillin JC. Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosom Med. 1992. 54:10–21.
30. Braun AR, Balkin TJ, Wesenten NJ, Carson RE, Varga M, Baldwin P, Selbie S, Belenky G, Herscovitch P. Regional cerebral blood flow throughout the sleep-wake cycle. Brain. 1997. 120:1173–1197.
31. Bonnet MH, Arand DL. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep. 1995. 18:581–588.
32. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implication. J Clin Endocrinol Metab. 2001. 86:3787–3794.
33. Renko AK, Hiltunen L, Laakso M, Rajala U, Keinanen-Kiukaanniemi S. The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract. 2005. 67:84–91.
34. Spiegel K, Tasall E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004. 141:846–850.
35. Weller L, Avinir O. Hassles, uplifts and quality of sleep. Percept Mot Skills. 1993. 76:571–576.
36. Hick RA, Garcia ER. Level of stress and sleep duration. Percept Mot Skills. 1987. 64:44–46.
37. Bastien CH, Vallieres A, Morin CM. Precipitating factors of insomnia. Behav Sleep Med. 2004. 2:50–62.
38. Quan SF, Katz R, Olson J, Bonekat W, Enright PL, Young T, Newman A. Factors associated with incidence and persistence of symptoms of disturbed sleep in an elderly cohort: the Cardiovascular Health Study. Am J Med Sci. 2005. 329:163–172.
39. Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med. 2003. 65:259–267.
40. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 1999. 84:2603–2607.
41. Lamarche CH, Ogilvie RD. Electrophysiological changes during the sleep onset period of psychophysiological insomniacs, psychiatric insomniacs, and normal sleepers. Sleep. 1997. 20:724–733.
42. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry. 2004. 161:2126–2128.
43. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987. 10:541–553.
44. Morin CM. Morin CM, editor. A cognitive-behavioral model of chronic insomnia. Insomnia: Psychological Assessment and Managemen. 1993. New York: Guilford.
45. Espie CA. Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults. Annu Rev Psychol. 2002. 53:215–243.
46. Edinger JD, Fins AI, Glenn DM, Sullivan RJ Jr, Bastian LA, Marsh GR, Dailey D, Hope TV, Young M, Shaw E, Vasilas D. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints? J Consult Clin Psychol. 2000. 68:586–593.
47. American Psychiatric Association. Diagnostic and Statistical manual of mental disorders. 1995. 4th ed (Korean translation version). Seoul: Hana medical publishing.
48. Ohayon MM, Shapiro CM. Sleep disturbances and psychiatric disorders associated with posttraumatic stress disorder in the general population. Compr Psychiatry. 2000. 41:469–478.
49. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry. 1996. 40:79–88.
50. Mellman T, Kumar A, Kulick-Bell R, Kumar M, Nolan B. Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol Psychiatry. 1995. 38:174–179.
51. Husain AM, Miller PP, Carwile ST. REM sleep behavior disorder: potential relationship to posttraumatic stress disorder. J Clin Neurophysiol. 2001. 18:148–157.
52. Germain A, Buysse DJ, Nofzinger E. Sleep-specific mechanisms underlying posttraumatic stress disorder: Integrative review and neurobiological hypotheses. Sleep Med Rev. 2008. 12:185–195.
53. Han KS. Stress of mid-life stage. Korean J Stress Res. 2007. 15:263–270.
54. Seaward BL. Managing stress-principles and strategies for health and well-being. 2009. 6th ed. Boston: Jones and Bartlett Pub.
55. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults. Sleep. 2005. 28:1049–1057.
56. McKernan RM, Whiting PJ. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci. 1996. 19:139–143.
57. Zhdanova IV. Advances in the management of insomnia. Expert Opin Pharmacother. 2004. 5:1573–1579.
58. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc. 2003. 78:1564–1577.
59. Roehrs T, Merlotti L, Zorick F, Roth T. Sedative, memory, and performance effects of hypnotics. Psychopharmacology. 1994. 116:130–134.
60. Sepracor I. Lunesta (eszopiclone tablets) product information. 2005. Marlborough, MA:
61. Miyamoto M, Nishikawa H, Doken Y, Hirai K, Uchikawa O, Ohkawa S. The sleep-promoting action of ramelteon (TAK-375) in freely moving cats. Sleep. 2004. 27:1319–1325.
62. Chavez B. Pharmacotherapy in managing insomnia: Assessing patient needs and outcomes. US Pharm. 2005. 2:HS23–HS26.
63. Aronson MD, Hafez H. A case of trazodone-induced ventricular tachycardia. J Clin Psychiatry. 1986. 47:388–389.
64. Sproule BA, Busto UE, Buckle C, Herrmann N, Bowles S. The use of non-prescription sleep products in the elderly. Int J Geriatr Psychiatry. 1999. 14:851–857.
65. Spoormaker VI, Montgomery P. Disturbed sleep in post-traumatic stress disorder: Secondary symptom or core feature? Sleep Medicine Reviews. 2008. 12:169–184.
66. Chesson AL Jr, Anderson WM, Littner M, Davila D, Hartse K, Johnson S, Wise M, Rafecas J. Practice parameters for the nonpharmacologic treatment of chronic insomnia. Sleep. 1999. 22:1128–1133.
67. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987. 10:45–56.
68. Hauri P. Current concepts: the sleep disorders. 1977. . Kalamanzoo MI: The Upjohn Company.
69. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999. 281:991–999.
70. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001. 285:1856–1864.
XML Download